Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep

Article Abstract:

Corticosteroids used during pregnancy may cause fetal growth retardation. These drugs are used to prevent premature birth and its complications. Researchers gave pregnant sheep one dose of betamethasone at 104 days' gestation, three doses at 104, 111, and 118 days, or saline solution as the control. Lambs were delivered prematurely at 125 days or at term at 145 days. Even the single dose was associated with fetal growth retardation and the multiple doses inhibited growth even more. This effect persisted at birth even in lambs born at term.

Author: Jobe, Alan H., Ervin, M. Gore, Ikegami, Machiko, Wada, Norihisa, Berry, Lynne M.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1998
Complications and side effects, Fetus, Fetal growth retardation, Growth disorders

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Differential effects of maternal betamethasone and cortisol on lung maturation and growth in fetal sheep

Article Abstract:

The hormone cortisol may not help a baby's lungs mature when given to pregnant women in premature labor, according to a study in sheep. Normally, these women are given a corticosteroid drug such as betamethasone or dexamethasone. However, betamethasone and dexamethasone can stunt the baby's growth. For this reason, some doctors recommend using cortisol.

Author: Jobe, Alan H., Newnham, John P., Ikegami, Machiko, Moss, Timothy J.
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2003
Lungs, Lung, Growth, Premature birth, Hydrocortisone, Company growth

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Single and multiple prenatal glucocorticoid exposures improve preterm newborn lamb cardiovascular and renal function

Article Abstract:

Research has been conducted on preterm newborn lamb cardiovascular and renal function. The athors have investigated the hypothesis that multiple betamethasone exposures would improve renal and cardiovascular adaptation.

Author: Jobe, Alan H., Ervin, M. Gore, Ikegami, Machiko, Smith, Lynne M., Wada, Norihisa
Publisher: Elsevier B.V.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2003
United States, Research and Development in the Physical, Engineering, and Life Sciences, Science & research, Research and Testing Services, Gynecological R&D, Health aspects, Care and treatment, Research, Analysis, Drug therapy, Infants (Newborn), Newborn infants, Kidneys, Cardiovascular system, Circulatory system, Premature labor, Cardiopulmonary system, Respiratory system, Kidney, Obstetrics, Gynecological research, Premature labour, Glucocorticoids

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Causes of, Corticosteroids, Adrenocortical hormones, Physiological aspects, Betamethasone
Similar abstracts:
  • Abstracts: Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. The diagnosis and treatment of cough
  • Abstracts: Restoring a single anterior tooth: Solutions to a dental dilemma. The fastest and best provisional restorations
  • Abstracts: Patient safety and medical malpractice: a case study. Obesity--The new frontier of public health law. The rise of litigation in human subjects research
  • Abstracts: Differential effects of natural and synthetic glucocorticoids on cytochrome 17alpha-hydroxylase (P-450(sub)17alpha) and cytochrome P-450 side-chain cleavage (P-450(sub)scc) messenger ribonucleic acid in the sheep placenta
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.